Patents by Inventor James G. Wetmur

James G. Wetmur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7495088
    Abstract: Disclosed is a nuclease resistant nucleotide compound capable of hybridizing with a complementary RNA in a manner which inhibits the function thereof, which modified nucleotide compound includes at least one component selected from the group consisting of MN3M, B(N)xM and M(N)xB wherein N is a phosphodiester-linked modified 2?-deoxynucleoside moiety; M is a moiety that confers endonuclease resistance on said component and that contains at least one modified or unmodified nucleic acid base; B is a moiety that confers exonuclease resistance to the terminus to which it is attached; and x is an integer of at least 2.
    Type: Grant
    Filed: June 28, 1994
    Date of Patent: February 24, 2009
    Assignee: Enzo Life Sciences, Inc.
    Inventors: Christine L. Brakel, James G. Wetmur, Robin S. Quartin
  • Patent number: 6358685
    Abstract: Procedures and compositions for forming and stabilizing non stable branch migrated oligo- and polydeoxynucleotides utilizing a displacer which is either single stranded or partially double stranded and hybridized to a linker strand. The displacer may contain one or more modified nucleotides.
    Type: Grant
    Filed: August 31, 1999
    Date of Patent: March 19, 2002
    Assignee: Enzo Therapeutics, Inc.
    Inventors: James G. Wetmur, Robin S. Quartin, Dean L. Engelhardt
  • Patent number: 6294325
    Abstract: Isolated nucleic acids which encode a thermostable protein that enhances specific binding of a thermostable mismatch binding protein to bulge loops in a heteroduplex nucleic acid and recombinant vectors comprising nucleic acid which encodes a thermostable protein that enhances specific binding of a thermostable mismatch binding protein to bulge loops in a heteroduplex nucleic acid are disclosed. Also disclosed are isolated thermostable proteins that enhance specific binding of a thermostable mismatch binding protein to bulge loops in a heteroduplex nucleic acid and host cells comprising a recombinant gene which can express a thermostable protein that enhances specific binding of a thermostable mismatch binding protein to bulge loops in a heteroduplex nucleic acid.
    Type: Grant
    Filed: July 5, 1996
    Date of Patent: September 25, 2001
    Assignee: The Mount Sinai School of Medicine of the City University of New York
    Inventor: James G. Wetmur
  • Patent number: 5958681
    Abstract: Procedures and compositions for forming and stabilizing non stable branch migrated oligo- and polydeoxynucleotides utilizing a displacer which is either single stranded or partially double stranded and hybridized to a linker strand. The displacer may contain one or more modified nucleotides.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 28, 1999
    Assignee: Enzo Therapeutics, Inc.
    Inventors: James G. Wetmur, Robin S. Quartin, Dean L. Engelhardt
  • Patent number: 5877280
    Abstract: Isolated nucleic acids which encode a thermostable protein which binds specifically to bulge loops in a heteroduplex nucleic acid and recombinant vectors comprising nucleic acid which encodes a thermostable protein which binds specifically to bulge loops in a heteroduplex nucleic acid are disclosed. Also disclosed are isolated thermostable proteins which bind specifically to bulge loops in a heteroduplex nucleic acid and host cells comprising a recombinant gene which can express a thermostable protein which binds specifically to bulge loops in a heteroduplex nucleic acid. Further disclosed are a method of reducing DNA misincorporation in an amplification reaction, methods for detecting a nucleic acid which includes a specific sequence, a method for amplifying a nucleic acid comprising a specific sequence, and a method for selecting against a nucleic acid comprising a specific sequence.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: March 2, 1999
    Assignee: The Mount Sinai School of Medicine of the City University of New York
    Inventor: James G. Wetmur
  • Patent number: 5840578
    Abstract: A DNA sequence encoding the .delta.-amino levulinate type 2 gene, methods to detect the gene, diagnostic kits to detect the gene and recombinant vectors containing the type 2 gene sequence.
    Type: Grant
    Filed: January 24, 1997
    Date of Patent: November 24, 1998
    Assignee: Mount Sinai School of Medicine of the City University of New York
    Inventors: Robert J. Desnick, James G. Wetmur
  • Patent number: 5639607
    Abstract: A method is disclosed for detecting a polymorphism in the .delta.-aminolevulinate dehydratase gene which is associated with an altered susceptibility to lead poisoning. A point mutation which generates an MspI restriction endonuclease recognition site was found in the ALAD2 allele of the .delta.-aminolevulinate dehydratase gene which is not present in the ALAD1 allele. Kit containing primers for the amplification of the polymorphic region of the ALAD gene are provided.
    Type: Grant
    Filed: February 14, 1994
    Date of Patent: June 17, 1997
    Assignee: Mount Sinai School of Medicine of the City University of New York
    Inventors: Robert J. Desnick, James G. Wetmur
  • Patent number: 4868103
    Abstract: A method is disclosed to detect the presence of an analyte. The method involves forming a complex comprising the analyte and a binding entity. The binding entity comprises a first partner of an energy transfer system. The complex is then contacted with a reporting entity to form a unit. The reporting entity comprises a second partner of the energy transfer system. The first partner and the second partner are within Furster's radius of each other in the formed unit. The unit is irradiated with energy which can only be absorbed by one of said partners, namely, the energy donor, which then emits fluorescent energy. Some of this energy is absorbed by the other of said partners, namely, the energy acceptor, which also emits fluorescent energy. However, the fluorescent energy of the energy acceptor is of longer wavelength and in addition may be of substantially greater duration than the fluorescent energy of the energy donor.
    Type: Grant
    Filed: February 19, 1986
    Date of Patent: September 19, 1989
    Assignee: Enzo Biochem, Inc.
    Inventors: Jannis Stavrianopoulos, Elazar Rabbani, Samuel B. Abrams, James G. Wetmur